Text-based mental health support provider HearMe and healthcare staffing firm Ingenovis Health partnered to create a free support system for travel nurses available 24/7.
Behavioral Health Technology
The mental health software market value is on track to reach $5.6 billion by 2028, led by three industry developments, according to a market research study published Aug. 8. by Facts and Factors.
Abbott's deep brain stimulation device was awarded the FDA's breakthrough device designation for treatment-resistant depression, Abbott said July 27.
Smitta Patel, MD, a psychiatrist at the UCLA Semel Institute for Neuroscience and Human Behavior, is joining VyTrac Health's medical advisory board.
Medical technology company Neuronetics will be the exclusive supplier of transcranial magnetic stimulation equipment used in the mental health treatment network of Arkansas-based Alleviant Health, Neuronetics said July 25.
Advertisement
In clinical trials, four in-development psychiatric drugs show promise for treatment of schizophrenia, postpartum depression and major depressive disorder, MDLinx reported July 21.
FDA approves Neuronetics' transcranial magnetic stimulation treatment for depression-related anxiety
The FDA has approved Neuronetics' transcranial magnetic stimulation system as a treatment for adults with major depressive disorder, the company said this week.
Wysa, an artificial intelligence digital mental health platform, nabbed $20 million in funding, the company said July 18.
Below are Forbes' top five virtual psychiatry platforms, determined considering costs, conditions treated, quality of providers and more, published July 14.
The U.S. has seen a broad push for increased mental health resources since the beginning of the COVID-19 pandemic, but staffing and provider counts are still woefully inadequate in some places.